Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
236.8 CHF | -1.00% | -0.25% | -9.41% |
Apr. 25 | The specter of stagflation rears its ugly head again | |
Apr. 25 | ROCHE : Barclays lowers target price | CF |
Business Summary
Number of employees: 103,605
Sales per Business
CHF in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceuticals
76.6
%
| 48,628 | 73.2 % | 46,279 | 76.6 % | -4.83% |
Diagnostics
23.4
%
| 17,798 | 26.8 % | 14,162 | 23.4 % | -20.43% |
Sales per region
CHF in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
46.9
%
| 29,313 | 44.1 % | 28,352 | 46.9 % | -3.28% |
Rest of Europe
16.1
%
| 10,328 | 15.5 % | 9,703 | 16.1 % | -6.05% |
Rest of Asia
14.7
%
| 9,852 | 14.8 % | 8,890 | 14.7 % | -9.76% |
Japan
7.4
%
| 6,452 | 9.7 % | 4,464 | 7.4 % | -30.81% |
Latin America
4.9
%
| 2,870 | 4.3 % | 2,971 | 4.9 % | +3.52% |
Germany
4.8
%
| 3,318 | 5.0 % | 2,893 | 4.8 % | -12.81% |
Africa, Australia and Oceania
2.0
%
| 1,520 | 2.3 % | 1,212 | 2.0 % | -20.26% |
Switzerland
1.8
%
| 1,671 | 2.5 % | 1,118 | 1.8 % | -33.09% |
Rest of North America
1.4
%
| 1,102 | 1.7 % | 838 | 1.4 % | -23.96% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 49 | 02-12-31 | |
Severin Schwan
CHM | Chairman | 57 | 07-12-31 |
Alan Hippe
DFI | Director of Finance/CFO | 57 | 11-03-31 |
Pascale Schmidt
CMP | Compliance Officer | 51 | 19-12-31 |
Levi Garraway
CTO | Chief Tech/Sci/R&D Officer | - | - |
Bruno Eschli
IRC | Investor Relations Contact | - | - |
Silke Hörnstein
PRN | Corporate Officer/Principal | 49 | 14-12-31 |
Annette Luther
SEC | Corporate Secretary | 54 | 20-03-31 |
General Counsel | 60 | 20-03-31 | |
Human Resources Officer | 57 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Bernard Poussot
BRD | Director/Board Member | 72 | 15-03-02 |
Director/Board Member | 59 | - | |
Director/Board Member | 65 | 95-12-31 | |
Patrick Frost
BRD | Director/Board Member | 56 | 20-03-16 |
Hans Clevers
PRN | Corporate Officer/Principal | 67 | 19-03-04 |
Severin Schwan
CHM | Chairman | 57 | 07-12-31 |
Anita Hauser
BRD | Director/Board Member | 55 | 17-03-13 |
Director/Board Member | 71 | 15-03-02 | |
Director/Board Member | 58 | 16-02-29 | |
Joerg Duschmale
BRD | Director/Board Member | 40 | 20-03-16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 106,691,000 | 28,989,189 ( 27.17 %) | 0 | 88.91 % |
Stock B | 1 | 702,562,700 | 690,549,764 ( 98.29 %) | 12,011,755 ( 1.710 %) |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
1,005,670,000 | 59.89% | 38,367,557,531 $ | |
ROCHE HOLDING AG 1.43% | 10,073,029 | 1.43% | 2,568,862,838 $ |
2,744,120 | 8.17% | 38,884,180 $ | |
454,961 | 3.02% | 13,357,655 $ | |
ALIGOS THERAPEUTICS, INC. 15.19% | 11,025,941 | 15.19% | 10,805,422 $ |
1,893 | 0.06% | 1,893 $ |
Company contact information
Group companies
Name | Category and Sector |
---|---|
Sapac Corp. Ltd.
| |
Roche Pharmholding BV
Roche Pharmholding BV Medical DistributorsDistribution Services Part of Roche Holding AG, Roche Pharmholding BV is a Dutch company that manufactures and distributes pharmaceutical and vitamin products. The private company is based in Woerden, Netherlands. |
Medical Distributors
|
Roche Finance Europe BV
|
Finance/Rental/Leasing
|
Roche Catalyst Investments Ltd.
| |
Roche Financial Investments Ltd.
| |
Roche Intertrade Ltd.
| |
Roche Diagnostics India Pvt Ltd.
Roche Diagnostics India Pvt Ltd. Medical SpecialtiesHealth Technology Founded in 1988, Roche Diagnostics India Pvt Ltd. is a subsidiary of Roche Holding AG. The private company is based in Mumbai, India. The Indian company manufactures diagnostic systems and devices for patients, clinicians, and researchers. |
Medical Specialties
|
Viewics India Pvt Ltd.
| |
Roche Financial Management Ltd.
|
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.17% | 562B | |
-6.33% | 358B | |
+19.90% | 322B | |
+7.95% | 297B | |
+13.45% | 219B | |
+6.04% | 199B | |
-12.26% | 149B | |
-6.47% | 146B | |
+2.07% | 117B |
- Stock Market
- Equities
- ROG Stock
- RO Stock
- Company Roche Holding AG